| Code | 2302F | ||||||||||
| MA number | 83/0449/25-S | ||||||||||
| Product Form: | tbl 100x5 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Teva B.V., Netherland | ||||||||||
| Therapeutic Class: | 83 - VASODILATANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 22.12.2025 |
| Validity: | 22.12.2030 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Amlodipine Teva 5 mg, 10 mg_12_2025.pdf
|
| SPC: |
SPC_Amlodipine Teva 5 mg, 10 mg_12_2025.pdf
|
| Safety feature | Yes |
| Data update: | 23.12.2025 |
